ABC transporters in lipid transport

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1486, Issue 1, 2000, Pages 128-144

  Borst, P ^a   Zelcer, N ^a   Van Helvoort, A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Lipid analogue; Mdr2 P glycoprotein; MDR2 P glycoprotein; MDR3 P glycoprotein; Multidrug resistance; Phosphatidylcholine translocator

Indexed keywords

ABC TRANSPORTER; CARRIER PROTEIN; CHIMERIC PROTEIN; GLYCOPROTEIN P; LIPID; MULTIDRUG RESISTANCE PROTEIN; PHOSPHATIDYLCHOLINE TRANSLOCATOR PROTEIN; PHOSPHATIDYLETHANOLAMINE; PROTEIN INHIBITOR; PROTEIN RIM; RETINAL; UNCLASSIFIED DRUG;

DRUG TRANSPORT; ENZYME SPECIFICITY; GENE CASSETTE; HUMAN; HYDROPHOBICITY; LIPID TRANSPORT; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; STARGARDT DISEASE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; BILE; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; DRUG RESISTANCE, MULTIPLE; GLYCOPROTEINS; HUMANS; LIPID METABOLISM; LIVER; MEMBRANE LIPIDS; MEMBRANE PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEINS; PHOSPHATIDYLCHOLINES; PHOSPHOLIPID TRANSFER PROTEINS; SUBSTRATE SPECIFICITY; TRANSFECTION;

RODENTIA;

EID: 0034717893     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(00)00053-6     Document Type: Review

References (105)

1. Smit J.J.M., Schinkel A.H., Oude Elferink R.P.J., Groen A.K., Wagenaar E., Van Deemter L., Mol C.A.A.M., Ottenhof R., Van der Lugt N.M.T., Van Roon M., Van der Valk M.A., Offerhaus G.J.A., Berns A.J.M., Borst P. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75:1993;451-462.
2. Ruetz S., Gros P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell. 77:1994;1071-1083.
3. Smith A.J., Timmermans-Hereijgers J.L.P.M., Roelofsen B., Wirtz K.W.A., Van Blitterswijk W.J., Smit J.J.M., Schinkel A.H., Borst P. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 354:1994;263-266.
4. Ruetz S., Gros P. Enhancement of Mdr2-mediated phosphatidylcholine translocation by the bile salt taurocholate. J. Biol. Chem. 270:1995;25388-25395.
5. van Helvoort A., Smith A.J., Sprong H., Fritzsche I., Schinkel A.H., Borst P., van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 87:1996;507-517.
6. Kino K., Taguchi Y., Yamada K., Komano T., Ueda K. Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins. FEBS Lett. 399:1996;29-32.
7. Higgins C.F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8:1992;67-113.
8. Kaur P., Russell J. Biochemical coupling between the DrrA and DrrB proteins of the doxorubicin efflux pomp of Streptomyces peucetius. J. Biol. Chem. 273:1998;17933-17939.
9. Saier M.H., Paulsen I.T., Sliwinski M.K., Pao S.S., Skurray R.A., Nikaido H. Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J. 12:1998;265-274.
10. Van Veen H.W., Venema K., Bolhuis H., Oussenko I., Kok J., Poolman B., Driessen A.J.M., Konings W.N. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc. Natl. Acad. Sci. USA. 93:1996;10668-10672.
11. Bolhuis H., Van Veen H.W., Molenaar D., Poolman B., Driessen A.J.M., Konings W.N. Multidrug resistance in Lactococcus lactis: evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane. EMBO J. 15:1996;4239-4245.
12. Regev R., Eytan G.D. Flip-flop of doxorubicin across erythrocyte and lipid membranes. Biochem. Pharmacol. 54:1997;1151-1158.
13. Higgins C.F., Gottesman M.M. Is the multidrug transporter a flippase? Trends Biochem. Sci. 17:1992;18-21.
14. Van Veen H.W., Callaghan R., Soceneantu L., Sardini A., Konings W.N., Higgins C.F. A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene. Nature. 391:1998;291-295.
15. Rosenberg M.F., Callaghan R., Ford R.C., Higgins C.F. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J. Biol. Chem. 272:1997;10685-10694.
16. Higgins C.F., Callaghan R., Linton K.J., Rosenberg M.F., Ford R.C. Structure of the multidrug resistance P-glycoprotein. Semin. Cancer Biol. 8:1997;135-142.
17. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427.
18. Senior A.E., Al-Shawi M.K., Urbatsch I.L. The catalytic cycle of P-glycoprotein. FEBS Lett. 377:1995;285-289.
19. Stein W.D. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol. Rev. 77:1997;545-590.
20. Shapiro A.B., Ling V. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250:1997;130-137.
21. Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M.V., Deeley G.R. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
22. Deeley R.G., Cole S.P.C. Function, evolution and structure of multidrug resistance protein (MRP). Semin. Cancer Biol. 8:1997;193-204.
23. Kool M., De Haas M., Scheffer G.L., Scheper R.J., Van Eijk M.J.T., Juijn J.A., Baas F., Borst P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologs of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:1997;3537-3547.
24. Borst P., Kool M., Evers R. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR? Semin. Cancer Biol. 8:1997;205-213.
25. Kool M., Van der Linden M., De Haas M., Baas F., Borst P. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res. 59:1999;175-182.
26. Evers R., Kool M., Van Deemter L., Jansen H., Calafat J., Oomen L.C.J.M., Paulusma C.C., Oude Elferink R.P.J., Baas F., Schinkel A.H., Borst P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 101:1998;1310-1319.
27. Kool M., Van der Linden M., De Haas M., Scheffer G.L., De Vree J.M.L., Smith A.J., Jansen G., Peters G.J., Ponne N., Scheper R.J., Oude Elferink R.P.J., Baas F., Borst P. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. USA. 96:1999;6914-6919.
28. König J., Rost D., Cui Y., Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology. 29:1999;1156-1163.
29. Kiuchi Y., Suzuki H., Hirohashi T., Tyson C.A., Sugiyama Y. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett. 433:1998;149-152.
30. Bakos E., Hegedüs T., Holló Z., Welker E., Tusnády G.E., Zaman G.J.R., Flens M.J., Váradi A., Sarkadi B. Membrane topology and glycosylation of the human multidrug resistance-associated protein. J. Biol. Chem. 271:1996;12322-12326.
31. Tusnády G.E., Bakos E., Váradi A., Sarkadi B. Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Lett. 402:1997;1-3.
32. Kast C., Gros P. Topology mapping of the amino-terminal half of multidrug resistance-associated protein by epitope insertion and immunofluorescence. J. Biol. Chem. 272:1997;26479-26487.
33. Bakos E., Evers R., Szakács G., Tusnády G.E., Welker E., Szabó K., De Haas M., Van Deemter L., Borst P., Váradi A., Sarkadi B. Functional multidrug resistance protein (MRP) lacking the N-terminal transmembrane domain. J. Biol. Chem. 273:1998;32167-32175.
34. Müller M., Meijer C., Zaman G.J.R., Borst P., Scheper R.J., Mulder N.H., De Vries E.G.E., Jansen P.L.M. Overexpression of the multidrug resistance associated protein (MRP) gene results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA. 91:1994;13033-13037.
35. 4 and structurally related conjugates. J. Biol. Chem. 269:1994;27807-27810.
36. Jedlitschky G., Leier I., Bucholz U., Center M., Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res. 54:1994;4833-4836.
37. Jedlitschky G., Leier I., Buchholz U., Barnouin K., Kurz G., Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56:1996;988-994.
38. Keppler D., Leier I., Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol. Chem. 378:1997;787-791.
39. Versantvoort C.H.M., Bagrij T., Wright K.A., Twentyman P.R. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int. J. Cancer. 63:1995;855-862.
40. Versantvoort C.H.M., Broxterman H.J., Bagrij T., Scheper R.J., Twentyman P.R. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br. J. Cancer. 72:1995;82-89.
41. Feller N., Broxterman H.J., Währer D.C.R., Pinedo H.M. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett. 368:1995;385-388.
42. Ishikawa T. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem. Sci. 17:1992;463-468.
43. Ishikawa T., Li Z.-S., Lu Y., Rea P.A. The GS-X pump in plant, yeast, and animal cells: structure, function, and gene expression. Biosci. Rep. 17:1997;189-207.
44. Zaman G.J.R., Lankelma J., Van Tellingen O., Beijnen J., Dekker H., Paulusma C.C., Oude Elferink R.P.J., Baas F., Borst P. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. USA. 92:1995;7690-7694.
45. Rappa G., Lorico A.L., Flavell R.A., Sartorelli A.C. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res. 57:1997;5232-5237.
46. Twentyman P., Bagrij T. The influence of glutathione metabolism on multidrug resistance in MRP-overexpressing cells. Drug Resist. Updates. 1:1998;121-127.
47. Loe D.W., Almquist K.C., Cole S.P., Deeley R.G. ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J. Biol. Chem. 271:1996;9683-9689.
48. r 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res. 58:1998;5130-5136.
49. Taguchi Y., Yoshida A., Takada Y., Komano T., Ueda K. Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP). FEBS Lett. 401:1997;11-14.
50. Flens M.J., Izquierdo M.A., Scheffer G.L., Fritz J.M., Meijer C.J.L.M., Scheper R.J., Zaman G.J.R. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res. 54:1994;4557-4563.
51. Zaman G.J.R., Flens M.J., van Leusden M.R., De Haas M., Mülder H.S., Lankelma J., Pinedo H.M., Scheper R.J., Baas F., Broxterman H.J., Borst P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. USA. 91:1994;8822-8826.
52. Evers R., Zaman G.J.R., Van Deemter L., Jansen H., Calafat J., Oomen L.C.J.M., Oude Elferink R.P.J., Borst P., Schinkel A.H. Basolateral localization and export activity of the human multidrug resistance-associated protein (MRP) in polarized pig kidney cells. J. Clin. Invest. 97:1996;1211-1218.
53. Schinkel A.H., Mayer U., Wagenaar E., Mol C.A.A.M., Van Deemter L., Smit J.J.M., Van der Valk M.A., Voordouw A.C., Spits H., Van Tellingen O., Zijlmans J.M.J.M., Fibbe W.E., Borst P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA. 94:1997;4028-4033.
54. Wijnholds J., Evers R., van Leusden M.R., Mol C.A.A.M., Zaman G.J.R., Mayer U., Beijnen J., Van der Valk M., Krimpenfort P., Borst P. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking MRP. Nat. Med. 11:1997;1275-1279.
55. Lorico A., Rappa G., Finch R.A., Yang D., Flavell R.A., Sartorelli A.C. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57:1997;5238-5242.
56. Oude Elferink R.P.J., Tytgat G.N.J., Groen A.K. The role of mdr2 P-glycoprotein in hepatobiliary lipid transport. FASEB J. 11:1997;19-28.
57. Van Nieuwkerk C.M.J., Oude Elferink R.P.J., Groen A.K., Ottenhoff R., Tytgat G.N.J., Dingemans K.P., Van den Bergh Weerman M.A., Offerhaus G.J.A. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology. 111:1996;165-171.
58. De Vree J.M.L., Jacquemin E., Sturm E., Cresteil D., Bosma P.J., Aten J., Deleuze J.-F., Desrochers M., Burdelski M., Bernard O., Oude Elferink R.P.J., Hadchouel M. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl. Acad. Sci. USA. 95:1998;282-287.
59. Jacquemin E., Cresteil D., Manouvrier S., Boute O., Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet. 353:1999;210-211.
60. Smith A.J., De Vree J.M.L., Ottenhof R., Oude Elferink R.P.J., Schinkel A.H., Borst P. Hepatocyte specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice. Hepatology. 28:1998;530-536.
61. Cohen D.E., Leonard M.R., Carey M.C. In vitro evidence that phospholipid secretion into bile may be coordinated intracellularly by the combined actions of bile salts and the specific phosphatidylcholine transfer protein of liver. Biochemistry. 33:1994;9975-9980.
62. A. van Helvoort, A. De Brouwer, R. Ottenhof, J.F.H.M. Brouwers, J. Wijnholds, J.H. Beijnen, A. Rijneveld, T. Van der Poll, M.A. Van der Valk, D. Majoor, W. Voorhout, K.W.A. Wirtz, R.P.J. Oude Elferink, P. Borst, Mice without phosphatidylcholine transfer protein have no defects in secretion of phosphatidylcholine into bile or into the lung airspaces, Proc. Natl. Acad. Sci. USA (1999) accepted.
63. Crawford A.R., Smith A.J., Hatch V.C., Oude Elferink R.P.J., Borst P., Crawford J.M. Hepatic secretion of phospholipid vesicles critically depends on mdr2 or MDR3 P-glycoprotein expression. J. Clin. Invest. 100:1997;2562-2567.
64. Oude Elferink R.P.J., Ottenhoff R., Van Marle J., Frijters C.M.G., Smith A.J., Groen A.K. Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse. J. Clin. Invest. 102:1998;1749-1757.
65. Buschman E., Gros P. The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein. Cancer Res. 54:1994;4892-4898.
66. A.J. Smith, A. van Helvoort, G. van Meer, A.H. Schinkel, P. Borst, K. Szabó, E. Welker, G. Szakács, A. Váradi, B. Sarkadi, MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping, J. Biol. Chem. (1999) submitted.
67. A.J. Smith, The Substrate Specificities of the Human MDR1 and MDR3 P-glycoproteins, Academic thesis, Universiteitsdrukkerij Grafische Dienst UvA, Amsterdam, 1998.
68. Szabó K., Welker E., Bakos E., Roninson I., Váradi A., Sarkadi B. Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1. Cooperation of the nucleotide binding domains. J. Biol. Chem. 273:1998;10132-10138.
69. Smit J.J.M., Schinkel A.H., Mol C.A.A.M., Majoor D., Mooi W.J., Jongsma A.P.M., Lincke C.R., Borst P. Tissue distribution of the human MDR3 P-glycoprotein. Lab. Invest. 71:1994;638-649.
70. 2+-ATPase and Phospholipid Organization in the Erythrocyte Membrane, Academic thesis, University Utrecht, Utrecht, 1996.
71. J.W. Smit, Excretory Mechanisms for Cationic Drugs: Role of P-glycoprotein and Other Organic Cation Transporters, Academic thesis, Ponsen and Looijen BV, Wageningen, 1997.
72. Chollet A., Kawashima E. DNA containing the base analogue 2-aminoadenine: preparation, use as hybridization probes and cleavage by restriction endonucleases. Nucleic Acids Res. 16:1988;305-317.
73. Mayer U., Wagenaar E., Dorobek B., Beijnen J.H., Borst P., Schinkel A.H. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC 833. J. Clin. Invest. 100:1997;2430-2436.
74. Buschman E., Gros P. Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes. Mol. Cell. Biol. 11:1991;595-603.
75. Zhang X., Collins K.I., Greenberger L.M. Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1. J. Biol. Chem. 270:1995;5441-5448.
76. Currier S.J., Kane S.E., Willingham M.C., Cardarelli C.O., Pastan I., Gottesman M.M. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1/MDR2 transporters. J. Biol. Chem. 267:1992;25153-25159.
77. Zhou Y., Gottesman M.M., Pastan I. Studies of human MDR1-MDR2 chimeras demonstrate the functional exchangeability of a major transmembrane segment of the multidrug transporter and phosphatidylcholine flippase. Mol. Cell. Biol. 19:1999;1450-1459.
78. 6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity. J. Cell Sci. 110:1997;75-83.
79. Raggers R.J., van Helvoort A., Evers R., van Meer G. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J. Cell Sci. 112:1999;415-422.
80. Kamp D., Haest C.W.M. Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane. Biochim. Biophys. Acta. 1372:1998;91-101.
81. Dekkers D.W.C., Comfurius P., Schroit A.J., Bevers E.M., Zwaal R.F.A. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry. 37:1998;14833-14837.
82. Decottignies A., Grant A.M., Nichols J.W., de Wet H., McIntosh D.B., Goffeau A. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yorp1. J. Biol. Chem. 273:1998;12612-12622.
83. Allikmets R., Singh N., Sun H., Shroyer N.F., Hutchinson A., Chidambaram A., Gerrard B., Baird L., Stauffer D., Pfeiffer A., Rattner A., Smallwood P., Li Y., Anderson K.L., Lewis R.A., Nathans J., Leppert M., Dean M., Lupski J.R. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat. Genet. 15:1997;236-245.
84. Illing M., Molday L.L., Molday R.S. The 220-kDa rim protein of retinal rod outer segments is a member of the ABC transporter superfamily. J. Biol. Chem. 272:1997;10303-10310.
85. Allikmets R., Shroyer N.F., Singh N., Seddon J.M., Lewis R.A., Bernstein P.S., Peiffer A., Zabriskie N.A., Li Y., Hutchinson A., Dean M., Lupski J.R., Leppert M. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 277:1997;1805-1807.
86. Weng J., Mata N.L., Azarian S.M., Tzekow R.T., Birch D.G., Travis G.H. Insights into the function of rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell. 98:1999;13-23.
87. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.-H., Roomp K., Van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O.F., Loubser O., Ouelette B.F.F., Fichter K., Ashbourne-Excoffon K.J.D., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J.P., Genest J., Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density in lipoprotein deficiency. Nat. Genet. 22:1999;336-345.
88. Bodzioch M., Orsó E., Klucken J., Langmann T., Böttcher A., Diederich W., Drobnik W., Barlage S., Büchler C., Porsch-Ozcürümez M., Kaminski W.E., Hahmann H.W., Oette K., Rothe G., Aslanidis C., Lackner K.J., Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22:1999;347-351.
89. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.C., Deleuze J.F., Brewer H.B., Duverger N., Denèfle P., Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22:1999;352-355.
90. Young S.G., Fielding C.J. The ABCs of cholesterol efflux. Nat. Genet. 22:1999;316-318.
91. Langmann T., Klucken J., Reil M., Liebisch G., Luciani M.F., Chimini G., Kaminski W.E., Schmitz G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257:1999;29-33.
92. Luciani M.F., Denizot F., Savary S., Mattei M.G., Chimini G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics. 21:1994;150-159.
93. Luciani M., Chimini G. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J. 15:1996;226-235.
94. Becq F., Hamon Y., Bajetto A., Gola M., Verrier B., Chimini G. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes. J. Biol. Chem. 272:1997;2695-2699.
95. Hamon Y., Luciani M.F., Becq F., Verrier B., Rubartelli A., Chimini G. Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood. 90:1997;2911-2915.
96. Y. Hamon, M.-F. Luciani, A. Moynault, J.-M. Freyssinet, G. Chimini, Subcellular localization of the mammalian ABC transporter ABC1, Abstract Book 60, 1999.
97. G. Schmitz, J. Klucken, C. Büchler, G. Liebisch, W. Drobnik, M. Porsch-Ozcürümez, W.E. Kaminski, The human ATP-binding cassette transporter 8 (ABC8) is a cholesterol sensitive gene which is involved in macrophage cholesterol transport, Abstract Book 60, 1999.
98. Tang X., Halleck M.S., Schlegel R.A., Williamson P. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science. 272:1996;1495-1497.
99. Siegmund A., Grant A., Angeletti C., Malone L., Nichols J.W., Rudolph H.K. Loss of Drs2p does not abolish transfer of fluorescence-labeled phospholipids across the plasma membrane of Saccharomyces cerevisiae. J. Biol. Chem. 273:1998;34399-34405.
100. E.H. Hettema, H.F. Tabak, Transport of fatty acids and metabolites across the peroxisomal membrane, Biochim. Biophys. Acta (1999) submitted.
101. Piper P., Mahé Y., Thompson S., Pandjaitan R., Holyoak C., Egner R., Mühlbauer M., Coote P., Kuchler K. The Pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast. EMBO J. 17:1998;4257-4265.
102. Borst P., Schinkel A.H. Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet. 13:1997;217-222.
103. Lincke C.R., Smit J.J., Van der Velde-Koerts T., Borst P. Structure of the human MDR3 gene and physical mapping of the human MDR locus. J. Biol. Chem. 266:1991;5303-5310.
104. Raymond M., Rose E., Housman D.E., Gros P. Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells. Mol. Cell. Biol. 10:1990;1642-1651.
105. Schinkel A.H., Borst P. Multidrug resistance mediated by P-glycoproteins. [Review]. Semin. Cancer Biol. 2:1991;213-226.